BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...focused real-world evidence company to expand into 20 additional indications. Existing seed investors Lux Capital, Village Global...
Items per page:
1 - 1 of 1
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...focused real-world evidence company to expand into 20 additional indications. Existing seed investors Lux Capital, Village Global...
Items per page:
1 - 1 of 1